Please use this identifier to cite or link to this item: http://www.repositorio.ufop.br/handle/123456789/3776
Full metadata record
DC FieldValueLanguage
dc.contributor.authorRaoult, Didier-
dc.contributor.authorScola, Bernard La-
dc.contributor.authorEnea, Maryse-
dc.contributor.authorFournier, Pierre Edouard-
dc.contributor.authorRoux, Véronique-
dc.contributor.authorFenollar, Florence-
dc.contributor.authorGalvão, Márcio Antônio Moreira-
dc.contributor.authorLamballerie, Xavier de-
dc.date.accessioned2014-11-11T18:45:50Z-
dc.date.available2014-11-11T18:45:50Z-
dc.date.issued2001-
dc.identifier.citationRAOULT, D. et al. A flea-associated rickettsia pathogenic for humans. Emerging Infectious Diseases, Atlanta, v. 7, n.1, p. 73-81, 2001. Disponível em: <https://wwwnc.cdc.gov/eid/article/7/1/70-0073_article>. Acesso em: 08 set. 2014.pt_BR
dc.identifier.issn1080-6059-
dc.identifier.urihttp://www.repositorio.ufop.br/handle/123456789/3776-
dc.description.abstractA rickettsia named the ELB agent, or “Rickettsia felis,” was identified by molecular biology techniques in American fleas in 1990 and later in four patients from Texas and Mexico. We attempted to isolate this rickettsia from infected fleas at various temperatures and conditions. A representative isolate of the ELB agent, the Marseille strain, was characterized and used to develop a microimmunofluorescence test that detected reactive antibodies in human sera. The ELB agent was isolated from 19 of 20 groups of polymerase chain reaction-proven infected fleas. The microimmunofluorescence results provided serologic evidence of infection by the ELB agent in four patients with fever and rash in France (2) and Brazil (2), supporting the pathogenic role of this rickettsia. Our successful isolation of this rickettsia makes it available for use in serologic tests to determine its clinical spectrum, prevalence, and distribution.pt_BR
dc.language.isoen_USpt_BR
dc.titleA flea-associated rickettsia pathogenic for humans.pt_BR
dc.typeArtigo publicado em periodicopt_BR
dc.rights.licenseEmerging Infectious Diseases is published by the Centers for Disease Control and Prevention, a U.S. Government agency. Therefore, all materials published in Emerging Infectious Diseases are in the public domain and can be used without permission. Fonte: Emerging Infectious Diseases <http://www.nc.cdc.gov/eid/page/copyright-and-disclaimers>. Acesso em: 04 set. 2014.pt_BR
Appears in Collections:DEMSC - Artigos publicados em periódicos

Files in This Item:
File Description SizeFormat 
ARTIGO_Fleaassociatedrickettsia.pdf206,94 kBAdobe PDFView/Open


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.